In Reply – Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019답변 중 - 코로나바이러스 질병 2019의 경우 렌질루맙의 임상적 이점 Published on 2021-03-012022-09-12 Journal: Mayo Clinic proceedings [키워드] clinical Reply [저자] Zelalem Temesgen, Saad S Kenderian, Andrew D Badley [Category] MERS, SARS, 진단, PMC URL [DOI] 10.1016/j.mayocp.2020.12.029 [Article Type] Comment [Source] PMC All Keywords 【제목키워드】 clinical, Reply,